Your browser doesn't support javascript.
loading
Phase II multicentre, double-blind, randomised trial of ustekinumab in adolescents with new-onset type 1 diabetes (USTEK1D): trial protocol.
Gregory, John W; Carter, Kymberley; Cheung, Wai Yee; Holland, Gail; Bowen-Morris, Jane; Luzio, Stephen; Dunseath, Gareth; Tree, Timothy; Yang, Jennie Hsiu Mien; Marwaha, Ashish; Ali, Mohammad Alhadj; Bashir, Nadim; Hutchings, Hayley Anne; Fegan, Greg W; Stenson, Rachel; Hiles, Stephen; Marques-Jones, Susie; Brown, Amy; Tatovic, Danijela; Dayan, Colin.
Afiliación
  • Gregory JW; Division of Population Medicine, Cardiff University, Cardiff, South Glamorgan, UK.
  • Carter K; Swansea Trials Unit (STU), Swansea University, Swansea, West Glamorgan, UK k.carter@swansea.ac.uk.
  • Cheung WY; Diabetes Research Unit Cymru (DRUC), Swansea University, Swansea, West Glamorgan, UK.
  • Holland G; Swansea Trials Unit (STU), Swansea University, Swansea, West Glamorgan, UK.
  • Bowen-Morris J; Diabetes Research Group, Cardiff University, Cardiff, South Glamorgan, UK.
  • Luzio S; Diabetes Research Unit Cymru (DRUC), Swansea University, Swansea, West Glamorgan, UK.
  • Dunseath G; Diabetes Research Unit Cymru (DRUC), Swansea University, Swansea, West Glamorgan, UK.
  • Tree T; Peter Gorer Department of Immunobiology, King's College London, London, UK.
  • Yang JHM; National Institute for Health Research (NIHR) Biomedical Research Center (BRC), Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
  • Marwaha A; Peter Gorer Department of Immunobiology, King's College London, London, UK.
  • Ali MA; National Institute for Health Research (NIHR) Biomedical Research Center (BRC), Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
  • Bashir N; Department of Molecular Genetics, Cumming School of Medicine, The University of Calgary, Calgary, Alberta, Canada.
  • Hutchings HA; Diabetes Research Group, Cardiff University, Cardiff, South Glamorgan, UK.
  • Fegan GW; Swansea Trials Unit (STU), Swansea University, Swansea, West Glamorgan, UK.
  • Stenson R; Swansea Trials Unit (STU), Swansea University, Swansea, West Glamorgan, UK.
  • Hiles S; Swansea Trials Unit (STU), Swansea University, Swansea, West Glamorgan, UK.
  • Marques-Jones S; Diabetes Research Group, Cardiff University, Cardiff, South Glamorgan, UK.
  • Brown A; Swansea Trials Unit (STU), Swansea University, Swansea, West Glamorgan, UK.
  • Tatovic D; Patient and Public Representative, Ammanford, West Glamorgan, UK.
  • Dayan C; Patient and Public Representative, Cardiff, UK.
BMJ Open ; 11(10): e049595, 2021 10 18.
Article en En | MEDLINE | ID: mdl-34663658
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 / Ustekinumab Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adolescent / Humans Idioma: En Revista: BMJ Open Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 / Ustekinumab Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adolescent / Humans Idioma: En Revista: BMJ Open Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido